The University of Chicago Header Logo

Connection

Lin Shen to Humans

This is a "connection" page, showing publications Lin Shen has written about Humans.
Connection Strength

0.097
  1. A disease-associated mutation that weakens ZAP70 autoinhibition enhances responses to weak and self-ligands. Sci Signal. 2021 02 02; 14(668).
    View in: PubMed
    Score: 0.022
  2. Achieving a quantitative understanding of antiretroviral drug efficacy. Clin Infect Dis. 2010 Nov 01; 51(9):1105-6; author reply 1106-7.
    View in: PubMed
    Score: 0.011
  3. A novel method for determining the inhibitory potential of anti-HIV drugs. Trends Pharmacol Sci. 2009 Dec; 30(12):610-6.
    View in: PubMed
    Score: 0.010
  4. Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection. J Allergy Clin Immunol. 2008 Jul; 122(1):22-8.
    View in: PubMed
    Score: 0.009
  5. Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs. Nat Med. 2008 Jul; 14(7):762-6.
    View in: PubMed
    Score: 0.009
  6. ZAP70, too little, too much can lead to autoimmunity. Immunol Rev. 2022 05; 307(1):145-160.
    View in: PubMed
    Score: 0.006
  7. ZAP-70 in Signaling, Biology, and Disease. Annu Rev Immunol. 2018 04 26; 36:127-156.
    View in: PubMed
    Score: 0.004
  8. A quantitative basis for antiretroviral therapy for HIV-1 infection. Nat Med. 2012 Feb 19; 18(3):446-51.
    View in: PubMed
    Score: 0.003
  9. Dose-response curve slope is a missing dimension in the analysis of HIV-1 drug resistance. Proc Natl Acad Sci U S A. 2011 May 03; 108(18):7613-8.
    View in: PubMed
    Score: 0.003
  10. Consistent inhibition of HIV-1 replication in CD4+ T cells by acyclovir without detection of human herpesviruses. J Virol. 2011 May; 85(9):4618-22.
    View in: PubMed
    Score: 0.003
  11. Discovery of entry inhibitors for HIV-1 via a new de novo protein design framework. Biophys J. 2010 Nov 17; 99(10):3445-53.
    View in: PubMed
    Score: 0.003
  12. Unstimulated primary CD4+ T cells from HIV-1-positive elite suppressors are fully susceptible to HIV-1 entry and productive infection. J Virol. 2011 Jan; 85(2):979-86.
    View in: PubMed
    Score: 0.003
  13. New approaches for quantitating the inhibition of HIV-1 replication by antiviral drugs in vitro and in vivo. Curr Opin Infect Dis. 2009 Dec; 22(6):574-82.
    View in: PubMed
    Score: 0.003
  14. Isolation of a cellular factor that can reactivate latent HIV-1 without T cell activation. Proc Natl Acad Sci U S A. 2009 Apr 14; 106(15):6321-6.
    View in: PubMed
    Score: 0.002
  15. Preferential cytolysis of peripheral memory CD4+ T cells by in vitro X4-tropic human immunodeficiency virus type 1 infection before the completion of reverse transcription. J Virol. 2008 Sep; 82(18):9154-63.
    View in: PubMed
    Score: 0.002
  16. Decay dynamics of HIV-1 depend on the inhibited stages of the viral life cycle. Proc Natl Acad Sci U S A. 2008 Mar 25; 105(12):4832-7.
    View in: PubMed
    Score: 0.002
  17. The HBV drug entecavir - effects on HIV-1 replication and resistance. N Engl J Med. 2007 Jun 21; 356(25):2614-21.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.